Natural aging, expression of fibrosis-related genes and collagen deposition in rat lung

Experimental Gerontology

Volumn 42, Issue 10, 2007, Pages 1003-1011

  Calabresi, Carmen ^b   Arosio, Beatrice ^b   Galimberti, Lorenza ^b   Scanziani, Eugenio ^b   Bergottini, Raffaella ^b   Annoni, Giorgio ^a   Vergani, Carlo ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Aging; Collagen; Fibrosis; Lung; Matrix metalloproteinases

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; LUNG FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; ZYMOGRAPHY;

AGING; ANIMALS; COLLAGEN; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION REGULATION; LUNG; MALE; MATRIX METALLOPROTEINASES; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

ANIMALIA; RATTUS;

EID: 34548703328     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2007.06.016     Document Type: Article

References (37)

1. Arthur M.J.P. Matrix degradation in the liver. Semin. Liver dis. 10 (1990) 47-55
2. Abrass C.K., Adcox M.J., and Raugi G.J. Aging associated changes in renal extracellular matrix. Am. J. Phatol. 146 (1995) 742-752
3. Angel P., Baumann I., Stein B., Delius H., Rahmsdorf H.J., and Herrlich P. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagen gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7 (1987) 2256-2266
4. Baker A.H., Zaltsman A.B., George S.J., and Newbay A.C. Divergent effectsof tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 110 (1998) 1478-1487
5. Benyon R.C., and Arthur M.J.P. Extracellular matrix degradation and the role of hepatic Stellate cells. Semin. Liver dis. 21 (2001) 373-384
6. Brinckerhoff C.E., Plucinska I.M., Sheldon C.A., and O'Connor G.T. Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retinoie-acid or dexamethasone. Biochemistry 25 (1986) 6378-6384
7. Chambered R.C., and Laurent G.J. Colagens. In: Crystal R.G., West J.B., Weibel E.R., and Barnes P.J. (Eds). The Lung: Scientific Fondations (1997), Lippincott-Raven Publishers, Philadelphia 707-727
8. Chomczynski P., and Sacchi N. Singl-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
9. D'Errico A., Scarani P., Colosimo E., Spina M., Grigioni W.F., and Mancini A.M. Changes in alveolar connective tissue of the ageing lung. Virchows. Archiv. A. Pathol. Anat. 415 (1989) 137-144
10. Ebihara T., Venkatesan N., Tanaka R., and Ludwig M.S. Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care. Med. 162 (2000) 1569-1576
11. Enright P.L., Kronmal R.A., Manolio T.A., schenker M.B., and Hyatt R.E. Respiratory muscle strenght in the elderly: correlates and reference values. Am. J. Respir. Crit. Care Med. 149 (1994) 430-438
12. Evers B.M., Townsend C.M., and Thompson J.C. Organ physiology of aging. Surg. Clin. North Am. 74 (1994) 2337
13. Gagliano N., Arosio B., Grizzi F., Masson S., Tagliabue J., Dioguardi N., Vergani C., and Annoni G. Reduced collagenolytic activity of matrix metalloproteinases and development of liver fibrosis, in the aging rat. Mech. Ageing Dev. 123 (2002) 413-425
14. Green F.H.Y., and Pinkerton K.E. Environmental determinantes of lung aging. In: Harding R., Pinkerton K.E., and Plopper C.G. (Eds). The Lung: Development, Aging and the Environment (2004), Elsevier, London 377-395
15. Gomez D., Alonso D., Yoshiji U., and Thorgeirsson P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol. 74 (1997) 111-122
16. Guedez L., Stetler-Stevenson W.G., Wolff L., Wang L., Fukushima P., Mansoor A., and Stetler-Stevenson M. In vitro super expression of programmed cell death of B cells by tissue inhibitor of metalloproteases-1. J. Clin. Invest. 102 (1998) 2002-2010
17. Herron G.S., Banda M.J., Clark E.J., Gavrilovic J., and Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cell II. Expression of collagenases and stromelysin activities is regulated by endogenus inhibitors. J. Biol. Chem. 261 (1986) 2814-2818
18. Ignotz R.A., and Massaguè J. Transforming growth factor-β1 stimulates the expression of fibronectin and collagen and their ibncorporation into the extracellular matrix. J. Biol. Chem. 261 (1986) 4337-4345
19. Iyer S.N., Gurujeyalakshmi G., and Giri S.N. Effect of Pirfenidone on procollagen gene expression at the transcriptional level in Bleomycin hamster model of lung. JPET 289 (1999) 211-218
20. Janssens J.P., Herrmann F., MacGee W., and Micjel M.P. Cause of death in older patients with anatomo-pathological evidence of chronic bronchitis or emphysema: a case-control study based on autopsy findings. J. Am. Gerietr. Soc. 49 (2001) 571-576
21. Laemmli U.K. Clevage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
22. Limper A.H., and Roman J. Fibronectin. A versatile Matrix protein with roles in thoracic development, repair and infection. Chest 101 (1992) 1663-1673
23. Lundback B., Lindberg A., Lindstrom M., Ronmark E., Jonsson A.C., Jonsson E., Larsson L.G., Andersson S., Sandstrom T., and Larsson K. Obstructive ling disease in Northern Sweden Studies: not 15% but 50% of smokers develop COPD? Report from obstructive lung disease in northern Sweden studies. Respir. Med. 97 (2003) 115-122
24. Malik A., Saltoun C.A., Yarnold P.R., and Grammer L.C. Prevalence of obstructive airways disease in the disadvantaged elderly of Chicago. Allergy Asthma Proc. 25 (2004) 169-173
25. Masumoto K., de Rooij J.D., Suita S., Rottier R., Tibboel D., and de Krijger R.R. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development. Histopatology 47 (2005) 410-419
26. McCormick L.L., Zhang Y., Tootell E., and Gilliam A.C. Anti-TGF-β treatment prevents skin and lung fibrosis in murine sclerodernatous graft-versus host disease: a model for human sceroderma. J. Immunol. 163 (1999) 5693-5699
27. Meyer K.C. Aging. Proc. Am. Thorac. Soc. 2 (2005) 433-439
28. Mozes M.M., Bottinger E.P., Jacott T.A., and Kopp J.B. Renal expression of fibrotic matrixproteins and the transforming growth factor-β (TGF-β) isoforms in TGF-β transgenic mice. J. Am. Soc. Nephrol. 10 (1999) 271-280
29. Nicoletti A., and Sassy-Prigent C. An alternative quantitative polymrase chain reaction method. Anal. Biochem. 236 (1996) 229-241
30. Selman M., Ruiz V., Cabrera S., Segura L., Ramirez R., Barrios R., and Pardo A. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing non degenerative lung microenvironment?. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L562-L574
31. Parks W.C., and Shapiro D.S. Matrix metalloproteinses in lung biology. Respir. Res. 2 (2001) 10-19
32. Peterson D.D., Pack A.I., Silage D.A., and Fishman A.P. Effects of aging on ventilatory and occlusion pressure responses to hypoxia and hipercapnia. Am. Rev. Respir. 124 (1981) 387-391
33. Shannon J.M., and Deterning R.R. Epithelial-mesenchymal interactions, in lung development. In: Mc.Donald J.A. (Ed). Lung Growth and Development (1997), Marcel Dekker, inc., New York 81-118
34. Sporn M.B., Roberts A.B., Wakefield L.M., and de Combrigghe B. Same recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell. Biol. 105 (1987) 1039-1045
35. Steward W. Marimastat (BB2516) current status of development. Cancer Chem. Pharmacol. 43 Suppl. (1999) S56-S60
36. Tack M., Altose M., and Cherniack N. Effect of aging on the perception of resistive ventilatory loads. Am. Rev. Respir. Dis. 126 (1982) 463-467
37. Tierney G.M., Griffin N.R., Stuart R.C., Kasem H., Lynch J.T., Brown P.D., Millar A.W., Steele R.J., and Parsons S.L. A pilot study of the safety and effects of the matrix metalloproteinases inhibitor marimastat in gastric cancer. Eur. J. Cancer 35 (1999) 563-568